Part,  Chapter, Paragraph

 1   II,     5.  1.  1|        Kidney Disease and End Stage Renal Disease~Hypertension and
 2   II,     5.  4.Acr|           Indicators~ESRF~End Stage Renal Failure~EUBIROD~European
 3   II,     5.  4.  1|       kidney failure (necessitating renal replacement therapy: dialysis
 4   II,     5.  4.  2|          complications - blindness, renal failure, gangrene and amputation
 5   II,     5.  4.  2|             and/or transplantation (renal replacement therapy in patients
 6   II,     5.  4.  2|           dialysis/transplantation (renal replacement therapy) in
 7   II,     5.  4.  2|             and/or transplantation (renal replacement therapy) per
 8   II,     5.  4.  2|          during the last 12 months.~Renal failure is measured as the
 9   II,     5.  4.  2|             12 months and End Stage Renal Failure (ESRF), which in
10   II,     5.  4.  3|         difference among age bands.~Renal failure. In EUCID only 8
11   II,     5.  4.  4|       Secondary outcomes, including renal failure, amputations, stroke,
12   II,     5.  7    |        kidney disease and end stage renal~disease~ ~
13   II,     5.  7.Acr|       Kidney Disease~ESRD~End Stage Renal Disease~EU~European Union~
14   II,     5.  7.Acr|             Modification of Diet in Renal Disease~NHANES III~National
15   II,     5.  7.Acr|          and Outcomes Framework~RRT~Renal Replacement Therapy~WHO~
16   II,     5.  7.  1|          two reasons: first because renal impairment may prelude to
17   II,     5.  7.  1|            development of end stage renal disease (ESRD), i.e. the
18   II,     5.  7.  1|            progression to end stage renal disease (ESRD),~CKD was
19   II,     5.  7.  1|           and the resulting cost of renal replacement treatments are
20   II,     5.  7.  1|     Esbjorner et al, 1997). Data on renal replacement therapy (RRT)
21   II,     5.  7.  1|       children are collected by the renal registries in Europe. Although
22   II,     5.  7.  1|       extra-renal manifestations of renal insufficiency that affect
23   II,     5.  7.  1|            Pontoriero et al, 2007). Renal transplantation is the most
24   II,     5.  7.  1|             the most cost-effective renal replacement therapy (White
25   II,     5.  7.  1|             dialysis patients (U.S. Renal Data System, 2005).~ ~Definitions~ ~
26   II,     5.  7.  1|   proteinuria)~blood abnormalities (renal tubular syndromes)~imaging
27   II,     5.  7.  2|            Registry of the European Renal Association - European Dialysis
28   II,     5.  7.  2|          number of EU Member States renal registries are able to provide
29   II,     5.  7.  2|           as non Member States have renal registries in development
30   II,     5.  7.  2|            stages of development of renal registries hampered comparisons
31   II,     5.  7.  2|            national and/or regional renal registries in Europe and
32   II,     5.  7.  2|            policies for the care of renal failure in the EU.~ ~For
33   II,     5.  7.  2|    countries. National and regional renal registries including individual
34   II,     5.  7.  2|         with information on primary renal disease and the start date
35   II,     5.  7.  2|          yearly surveys among their renal centres. As availability
36   II,     5.  7.  2|            of national and regional renal registries and the completeness
37   II,     5.  7.  2|            period 1996-2000 from 16 renal registries in 9 EU-15 Member
38   II,     5.  7.  3|              286 pmp in 2005) (U.S. Renal Data System, USRDS, 2007)
39   II,     5.  7.  3|          group, gender and cause of renal failure.~ ~Table 5.7.4.
40   II,     5.  7.  3|           it was in other areas (UK Renal Registry, 2003).~ ~Prevalence~ ~
41   II,     5.  7.  3|          Canadians (1003 pmp) (U.S. Renal Data System, USRDS ,2007).~ ~
42   II,     5.  7.  3|          group, gender and cause of renal failure.~ ~Trends over time~ ~
43   II,     5.  7.  3|              Sixth Annual Report UK Renal Registry, 2003; Warady and
44   II,     5.  7.  3|          group, gender and cause of renal failure.~ ~Trends over time~ ~
45   II,     5.  7.  4|       According to data from the UK Renal Registry (UK Renal Registry,
46   II,     5.  7.  4|           the UK Renal Registry (UK Renal Registry, 2003), the prevalence
47   II,     5.  7.  5|             the quality of care for renal patients.~· In Spain there
48   II,     5.  7.  5|             which concerned chronic renal failure: (1) to stabilize (
49   II,     5.  7.  5|        reduce the impact of chronic renal failure on quality of life,
50   II,     5.  7.  5|            not compulsory.~· The UK Renal Registry monitors the quantity
51   II,     5.  7.  5|             hospital based clinical renal IT systems. The NHS Healthcare
52   II,     5.  7.  5|            this in Scotland. The UK Renal Association has developed
53   II,     5.  7.  5|     standards for audit measures in Renal Services. The NHS in England
54   II,     5.  7.  5|      national service framework for renal services. Although CKD has
55   II,     5.  7.  5|           the implementation of the Renal National Service Framework (
56   II,     5.  7.  6|           rolled out in a number or renal units in the UK offers a
57   II,     5.  7.  6|           the national and regional renal registries in EU Member
58   II,     5.  7.  6|             records and by bringing renal registries in development
59   II,     5.  7.  6| availability of cadaver kidneys for renal transplantation is far below
60   II,     5.  7.  7|         Bethesda, MD: United States Renal Data System, National Institute
61   II,     5.  7.  7|             Epidemiology of chronic renal failure in children: data
62   II,     5.  7.  7|   cardiovascular disease in chronic renal failure. Lancet 2000 Jul
63   II,     5.  7.  7|        Obesity and risk for chronic renal failure. J Am Soc Nephrol
64   II,     5.  7.  7|             Epidemiology of chronic renal failure in children: a report
65   II,     5.  7.  7|      incidence of treated end-stage renal failure in The Netherlands:
66   II,     5.  7.  7|   Epidemiologia de la Insuficiencia Renal Cronica en Espana (2007):
67   II,     5.  7.  7|          The incidence of end-stage renal disease is increasing faster
68   II,     5.  7.  7|           the prevalence of chronic renal insufficiency. Ann Intern
69   II,     5.  7.  7|            rise in the incidence of renal replacement therapy in developed
70   II,     5.  7.  7|         disease: focus on end-stage renal disease treated with hemodialysis.
71   II,     5.  7.  7|             Modification of Diet in Renal Disease Study Group. Ann
72   II,     5.  7.  7|             Epidemiology of chronic renal disease in the Galician
73   II,     5.  7.  7|      Organization and Financing for renal replacement therapy in Italy:
74   II,     5.  7.  7|          Trends in the incidence of renal replacement therapy for
75   II,     5.  7.  7|   replacement therapy for end-stage renal disease in Europe, 1990-
76   II,     5.  7.  7|          the incidence of end-stage renal disease in Europe, Canada
77   II,     5.  8.  3|       arrhythmias, angina, MI, CHF, renal disease, pulmonary embolism (
78   II,     6.  3.  6|            to a severe disease with renal failure and haemorrhages:
79   II,     6.  3.  6|          the leading cause of acute renal failure in children, and
80   II,     6.  3.  7|             haemorrhagic fever with renal syndrome~ ~Puumala haemorrhagic
81   II,     6.  3.  7|             haemorrhagic fever with renal syndrome, also callednephropathia
82   II,     6.  3.  7|             haemorrhagic fever with renal syndrome, with a death rate
83   II,     9.  3.  1|            circulatory diseases and renal failure.~ ~Ischemic heart
84   II,     9.  3.  1|            circulatory diseases and renal failure. In 2005, more than
85   II,     9.  3.  1|          which includes the risk of renal impairment.~ ~Pelvic floor
86  III,    10.  2.  1|           Urinary bladder~- Kidney (renal pelvis and renal cell carcinoma)~-
87  III,    10.  2.  1|            Kidney (renal pelvis and renal cell carcinoma)~- Uterine
88   IV,    11.  5.  1|             treatment for end-stage renal failure, while for end-stage
89   IV,    11.  5.  1|        Europe, initially limited to renal transplantation and later
90   IV,    11.  5.  6|          European co-operation~1987 Renal transplantation: sense and
91   IV,    13.  7    |             treatment for end-stage renal, liver, lung and heart failure.~ ~
92  Key,   Ap5.  0.  0|           reimbursement~remediation~renal~renewable~replacement~reproductive~